首页 › 急性髓系白血病 › 密歇根州 › Ann Arbor
Ann Arbor MI 急性髓系白血病临床试验
17项针对 急性髓系白血病的研究正在 Ann Arbor及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
招募中2 期
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距离 7 英里
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 距离 15 英里
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 距离 18 英里
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距离 7 英里
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 距离 15 英里
- 以及另外 1 项
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
招募中1 期
- C S Mott Children's Hospital, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 距离 7 英里
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距离 7 英里
- 以及另外 4 项
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
招募中2 期
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距离 7 英里
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 距离 15 英里
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 距离 18 英里
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
招募中3 期
- Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · 距离 7 英里
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
招募中2 期
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距离 7 英里
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 距离 15 英里
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 距离 18 英里
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
招募中2 期
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距离 7 英里
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 距离 15 英里
- 以及另外 1 项
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
招募中2 期
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距离 7 英里
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 距离 15 英里
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 距离 18 英里
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
招募中3 期
- C S Mott Children's Hospital, Ann Arbor
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
招募中3 期
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- C S Mott Children's Hospital, Ann Arbor
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
招募中3 期
- C.S. Mott Children's Hospital, Ann Arbor
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- University of Michigan, Ann Arbor
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- University of Michigan, Ann Arbor
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
招募中1 期
- University of Michigan, Ann Arbor
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- University of Michigan Comprehensive Cancer Center, Ann Arbor
其他城市的 急性髓系白血病试验
- Houston, TX85 项研究
- New York City, NY51 项研究
- Boston, MA44 项研究
- Seattle, WA41 项研究
- Baldwin Park, CA40 项研究
- Columbus, OH35 项研究
- Philadelphia, PA34 项研究
- Durham, NC33 项研究
- Atlanta, GA31 项研究
- Tampa, FL29 项研究
- Chicago, IL26 项研究
- Portland, OR25 项研究
Ann Arbor的其他研究
- 乳腺癌27 项研究
- 前列腺癌27 项研究
- 非小细胞肺癌26 项研究
- 癌症（所有类型）25 项研究
- 肺癌23 项研究
- 结直肠癌23 项研究
- 心力衰竭22 项研究
- 心血管疾病16 项研究
- 胰腺癌14 项研究
- 黑色素瘤12 项研究
- 卒中12 项研究
- 头颈鳞状细胞癌12 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。